Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles – Abstract
This article reports on the micro- and nanonization of meloxicam (MEL) with the aim of developing pre-dispersions as intermediates for the design of intranasal formulations. As a new approach, combined wet milling technology was developed in order to reduce the particle size of the MEL.